These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8488195)

  • 1. [Biological standardization of Ginkgo extracts].
    Steinke B; Müller B; Wagner H
    Planta Med; 1993 Apr; 59(2):155-60. PubMed ID: 8488195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bioavailability of ginkgolides in Ginkgo biloba extracts.
    Li CL; Wong YY
    Planta Med; 1997 Dec; 63(6):563-5. PubMed ID: 9434615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pharmacokinetics of ginkgo terpene lactones and impact of carboxylation in blood on their platelet-activating factor antagonistic activity.
    Liu XW; Yang JL; Niu W; Jia WW; Olaleye OE; Wen Q; Duan XN; Huang YH; Wang FQ; Du FF; Zhong CC; Li YF; Xu F; Gao Q; Li L; Li C
    Acta Pharmacol Sin; 2018 Dec; 39(12):1935-1946. PubMed ID: 30054600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts.
    Koch E
    Phytomedicine; 2005 Jan; 12(1-2):10-6. PubMed ID: 15693702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of extraction technique and validation of developed RP-HPLC-ELSD method for determination of terpene trilactones in Ginkgo biloba leaves.
    Kaur P; Chaudhary A; Singh B; Gopichand
    J Pharm Biomed Anal; 2009 Dec; 50(5):1060-4. PubMed ID: 19616398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans.
    Woelkart K; Feizlmayr E; Dittrich P; Beubler E; Pinl F; Suter A; Bauer R
    Phytother Res; 2010 Mar; 24(3):445-50. PubMed ID: 20041430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals.
    van Beek TA; Montoro P
    J Chromatogr A; 2009 Mar; 1216(11):2002-32. PubMed ID: 19195661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF).
    Smith PF; Maclennan K; Darlington CL
    J Ethnopharmacol; 1996 Mar; 50(3):131-9. PubMed ID: 8691847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
    Kuo If; Chen J; Chang TK
    Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an alternative method for determination of terpene lactones in ginkgo dry extract.
    Ekman L; Fransson D; Claeson P; Johansson M
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):67-71. PubMed ID: 20144453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes.
    Chang TK; Chen J; Teng XW
    Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of ginkgolide A, B, and bilobalide in biloba L. extracts by microdialysis-HPLC.
    Chiu HL; Lin HY; Yang TC
    Anal Bioanal Chem; 2004 Jun; 379(3):445-8. PubMed ID: 15057504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators.
    Chatterjee SS; Kondratskaya EL; Krishtal OA
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S68-77. PubMed ID: 13130392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of capillary gas chromatographic method for determination of bilobalide and ginkgolides A, B, C in Ginkgo biloba dry and liquid extracts.
    Krzek J; Czekaj JS; Rzeszutko W; Ekiert RJ
    Acta Pol Pharm; 2007; 64(4):303-10. PubMed ID: 18536155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
    Braquet P
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():179-98. PubMed ID: 2949548
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists.
    Vogensen SB; Strømgaard K; Shindou H; Jaracz S; Suehiro M; Ishii S; Shimizu T; Nakanishi K
    J Med Chem; 2003 Feb; 46(4):601-8. PubMed ID: 12570381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two new ginkgolides from the leaves of Ginkgo biloba.
    Liao HJ; Zheng YF; Li HY; Peng GP
    Planta Med; 2011 Nov; 77(16):1818-21. PubMed ID: 21614751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginkgo biloba leaf extract reverses amyloid beta-peptide-induced isoprostane production in rat brain in vitro.
    Brunetti L; Orlando G; Menghini L; Ferrante C; Chiavaroli A; Vacca M
    Planta Med; 2006 Nov; 72(14):1296-9. PubMed ID: 17022004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the callus cultures of Ginkgo biloba and its metabolites-ginkgolides.
    Yu R; Zhao H; Zheng Y; Yao X; Zhang H
    Chin J Biotechnol; 1999; 15(1):51-8. PubMed ID: 10668135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis and structure identification of trace constituent in the total ginkgolide by using LC/DAD/ESI/MS].
    Wang Y; Sheng LS; Lou FC
    Yao Xue Xue Bao; 2001 Aug; 36(8):606-8. PubMed ID: 12579939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.